Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Little Impact of Antiplatelet Agents on Venous Thromboembolism after Hip Fracture Surgery

Ji HM, Lee YK, Ha YC, Kim KC, Koo KH

Since the late 1980s, low dose aspirin has been used to prevent stroke and ischemic heart disease. However, prophylactic effect of antiplatelets against venous thromboembolism (VTE), in patients who undergo...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention of Venous Thromboembolism in Medical Intensive Care Unit: A Multicenter Observational Study in Korea

Lee J, Kim SC, Kim SJ, Oh JY, Lee HK, Yum HK, Kim YK, Hong SB, Park MS, Hwang SC, Yoon HK, Kim HR, Cho JH, Park S, Yoo CG

Patients admitted to medical intensive care unit (MICU) are at increased risk for venous thromboembolism (VTE); and prophylaxis is recommended. However, the actual range and frequency of VTE prophylaxis administered...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Mid-Term Efficacy and Safety of a Permanent Nitinol IVC Filter (TrapEase)

Liu WC, Do YS, Choo SW, Kim DI, Kim YW, Kim DK, Shin SW, Park KB, Jeon YH, Choo IW

OBJECTIVE: 1) To evaluate the mid-term efficacy and safety of a permanent nitinol inferior vena cava (IVC) filter; 2) to evaluate filter effectiveness, filter stability and caval occlusion. MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anticoagulation in cirrhosis: a new paradigm?

Leonardi F, Maria ND, Villa E

The liver plays a crucial role in coagulation cascade. Global hemostatic process is profoundly influenced by the presence of liver disease and its complications. Patients with cirrhosis have impaired synthesis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry

Jang JH, Kim JS, Yoon SS, Lee JH, Kim YK, Jo DY, Chung J, Sohn SK, Lee JW

Paroxysmal nocturnal hemoglobinuria (PNH) is a progressive, systemic, life-threatening disease, characterized by chronic uncontrolled complement activation. A retrospective analysis of 301 Korean PNH patients who had not received eculizumab was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr